GPBAR1 and pancreatic serous cystadenoma: In 2010, sequencing of GPBAR1 in 267 patients with primary sclerosing cholangitis (PSC) rendered five non-synonymous mutations that can reduce TGR5 function, but no data on plasma lipid parameters were reported [150].